These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29906264)

  • 1. The SYNTAX II Score Predicts Mortality at 4 Years in Patients Undergoing Percutaneous Coronary Intervention.
    Brener SJ; Alapati V; Chan D; Da-Wariboko A; Kaid Y; Latyshev Y; Moussa A; Narayanan CA; O'Laughlin JP; Raizada A; Verma G; Sacchi TJ
    J Invasive Cardiol; 2018 Aug; 30(8):290-294. PubMed ID: 29906264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.
    Yang CH; Hsieh MJ; Chen CC; Chang SH; Wang CY; Lee CH; Hsieh IC
    Coron Artery Dis; 2012 Nov; 23(7):445-9. PubMed ID: 22968215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive Value of Combining the Ankle-Brachial Index and SYNTAX Score for the Prediction of Outcome After Percutaneous Coronary Intervention (from the SHINANO Registry).
    Ueki Y; Miura T; Miyashita Y; Motoki H; Shimada K; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Hashizume N; Sekimura N; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
    Am J Cardiol; 2016 Jan; 117(2):179-85. PubMed ID: 26684515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with prior heart failure undergoing percutaneous coronary intervention: sub-analysis of the SHINANO registry.
    Minamisawa M; Miura T; Motoki H; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Senda K; Morita T; Hashizume N; Abe N; Ebisawa S; Izawa A; Miyashita Y; Koyama J; Ikeda U;
    Heart Vessels; 2017 Apr; 32(4):399-407. PubMed ID: 27709325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.
    Xu B; Généreux P; Yang Y; Leon MB; Xu L; Qiao S; Wu Y; Yan H; Chen J; Zhao Y; Zhao Y; Palmerini T; Stone GW; Gao R
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1128-37. PubMed ID: 25240551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of syntax score with short-term outcomes among acute ST-elevation myocardial infarction patients undergoing primary PCI.
    Choudhary S
    Indian Heart J; 2017 Apr; 69 Suppl 1(Suppl 1):S20-S23. PubMed ID: 28400034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Baseline Angiographic Complexities Determined by Coronary Artery Bypass Grafting SYNTAX Score on the Prediction of Outcome After Percutaneous Coronary Intervention.
    Nakahashi T; Sakata K; Nomura A; Yakuta Y; Gamou T; Terai H; Horita Y; Ikeda M; Namura M; Takamura M; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Oct; 118(7):974-9. PubMed ID: 27521219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SYNTAX Score-II Predicts Long-Term Mortality in Patients Who Underwent Left Main Percutaneous Coronary Intervention Treated With Second-Generation Drug-Eluting Stents.
    He J; Zhao H; Yu X; Li Q; Lv S; Chen F; Jiang T
    Int Heart J; 2017 May; 58(3):344-350. PubMed ID: 28539567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity.
    Migliorini A; Valenti R; Parodi G; Vergara R; Buonamici P; Cerisano G; Carrabba N; Antoniucci D
    JACC Cardiovasc Interv; 2016 May; 9(10):1001-7. PubMed ID: 27198680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of percutaneous coronary intervention for unprotected left main coronary artery according to the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score.
    Shiyovich A; Perl L; Vaknin-Assa H; Greenberg G; Samara A; Kornowski R; Assali A
    Coron Artery Dis; 2020 Jun; 31(4):336-341. PubMed ID: 31913167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term prognostic value of baseline SYNTAX and clinical SYNTAX scores in ST-segment elevation myocardial infarction patients with multivessel disease.
    Onuk T; Güngör B; İpek G; Karataş MB; Çanga Y; Akyüz Ş; Haci R; Karadeniz FÖ; Sungur A; Kaşikçioğlu H; Çam N
    Coron Artery Dis; 2016 Jun; 27(4):311-8. PubMed ID: 26945185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identify Unsuitable Patients with Left Main Coronary Artery Disease in Intermediate SYNTAX Scores Treated by Percutaneous Coronary Intervention.
    Zhang C; Zheng Y; Liu X; Cheng Y; Liu Y; Yao Y; Wang X; Xu J
    Heart Surg Forum; 2017 Dec; 20(6):E258-E262. PubMed ID: 29272225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.